Cargando…
Brain capillary obstruction during neurotoxicity in a mouse model of anti-CD19 chimeric antigen receptor T-cell therapy
Immunotherapy for haematologic malignancies with CD19-directed chimeric antigen receptor T cells has been highly successful at eradicating cancer but is associated with acute neurotoxicity in ∼40% of patients. This neurotoxicity correlates with systemic cytokine release syndrome, endothelial activat...
Autores principales: | Faulhaber, Lila D., Phuong, Anthea Q., Hartsuyker, Kendra Jae, Cho, Yeheun, Mand, Katie K., Harper, Stuart D., Olson, Aaron K., Garden, Gwenn A., Shih, Andy Y., Gust, Juliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833245/ https://www.ncbi.nlm.nih.gov/pubmed/35169706 http://dx.doi.org/10.1093/braincomms/fcab309 |
Ejemplares similares
-
IMMU-02. CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL NEUROTOXICITY CORRELATES WITH PRETREATMENT AND ACUTE CSF NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS
por: Gust, Juliane, et al.
Publicado: (2020) -
Cytokines in CAR T Cell–Associated Neurotoxicity
por: Gust, Juliane, et al.
Publicado: (2020) -
Antibody-based in vivo leukocyte label for two-photon brain imaging in mice
por: Faulhaber, Lila D., et al.
Publicado: (2022) -
Immunotherapy Associated Neurotoxicity in Pediatric Oncology
por: Shalabi, Haneen, et al.
Publicado: (2022) -
How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity
por: Santomasso, Bianca D., et al.
Publicado: (2023)